Volume 3, Issue 4 | April 2025
|
|
|
|
|
|
|
Mayo Clinic develops, manages, protects and licenses technology that saves lives and advances healthcare. We are continually seeking collaborators to help bring innovative solutions to market.
|
|
|
|
Explore an array of innovations available for licensing that are designed to enhance diagnostics, treatment and patient outcomes.
|
|
|
|
|
|
|
|
|
|
Tomorrow’s Cure: How AI enhances skin allergy testing
A new AI-powered solution offers a faster and more accurate way to diagnose skin conditions from a patient's own home. In this podcast episode, Charles Bruce, MD, ChB, chief innovation officer at Mayo Clinic in Florida, and Alison Bruce, MD, ChB, dermatologist at Mayo Clinic, discuss how they are reimagining the future of skin patch testing. Read more...
|
|
|
|
Cardiologists are first in world to use new TAVR catheter from Boston Scientific
A new catheter designed to assist interventional cardiologist during transcatheter aortic valve replacement (TAVR) procedures is both safe and effective, according to a new first-in-human study published in JACC: Cardiovascular Interventions. "The present study is the first to test a purpose-built catheter for retrograde AV crossing during TAVR procedures," says first author Mackram F. Eleid, MD, a cardiologist and echocardiographer at Mayo Clinic.
Read more...
|
|
|
|
Mayo Clinic launches landmark study on rare neurological disease
A groundbreaking natural history study led by researchers at Mayo Clinic's Center for Individualized Medicine and Department of Clinical Genomics is advancing research for one rare disease, with the potential to benefit many others. Read more...
|
|
|
|
DispatchHealth and Medically Home to merge, increasing access to hospital-level care at home
The combined entity will extend care into the homes of patients across 50 major metropolitan areas in partnership with nearly 40 health systems.
|
|
|
|
Mayo Clinic announces transformative $1.9B investment in Arizona
The investment underscores Mayo Clinic's leadership in creating a next-generation healthcare model that scales solutions for more patients.
|
|
|
|
Bread & Butter Ventures announces $40M Fund IV to invest in seed-stage startups
Participating companies include 3M, Cargill, Ecolab, General Mills, Hennepin Healthcare, Mayo Clinic, Minnesota Twins, Target, U.S. Bank, and more.
|
|
|
|
Find Mayo Clinic Business Development staff at these upcoming conferences:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Want to view past issues of Business Development’s e-newsletter?
|
|
|
|
|
|
|
|
|
|
About Business Development
|
Business Development is Mayo Clinic’s front door to business – from technology commercialization to strategic partnerships – catalyzing innovation to shape the future of healthcare for the benefit of patients.
The department bridges the gaps between industry and commercial groups to produce meaningful, effective changes in transforming health and medicine.
|
|
|
|
|
|
|
|
|
